Localization, characterization, and second messenger coupling of pituitary adenylate cyclase-activating polypeptide receptors in the fetal human adrenal gland during the second trimester of gestation

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 4, 1998, Pages 1299-1305

  Yon, Laurent ^a   Breault, Lyne ^b,d   Contesse, Vincent ^a   Bellancourt, Grégory ^a,e   Delarue, Catherine ^a   Fournier, Alain ^c   Lehoux, Jean Guy ^b   Vaudry, Hubert ^a,c   Gallo Payet, Nicole ^b  

^a UNIVERSITÉ DE ROUEN   (France)

^b UNIVERSITY OF SHERBROOKE   (Canada)

^c INSTITUT NATIONAL DE LA RECHERCHE SCIENTIFIQUE   (Canada)

^d Fonds pour Form Chercheurs l'A ^*

^e Conseil Reg de Haute Normandie ^*

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE ACTIVATOR;

ADRENAL GLAND; ARTICLE; AUTORADIOGRAPHY; FETUS; GESTATIONAL AGE; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; SECOND MESSENGER; SECOND TRIMESTER PREGNANCY; TISSUE DISTRIBUTION;

ADRENAL GLANDS; ANALYSIS OF VARIANCE; AUTORADIOGRAPHY; CELLS, CULTURED; EMBRYONIC AND FETAL DEVELOPMENT; FEMALE; HUMANS; LOGISTIC MODELS; PREGNANCY; PREGNANCY TRIMESTER, SECOND; RECEPTORS, PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RECEPTORS, PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE, TYPE I; RECEPTORS, PITUITARY HORMONE; SECOND MESSENGER SYSTEMS;

EID: 0031790088     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.4.1299     Document Type: Article

References (51)

1. Miyata A, Arimura A, Dahl R, et al. 1989 Isolation of a novel 38-residues hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem Biophys Res Commun. 164:567-574.
2. Miyata A, Jiang L, Dahl R, et al. 1990 Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase-activating polypeptide with 38-residues (PACAP 38). Biochem Biophys Res Commun. 170:643-648.
3. Arimura A. 1992 Pituitary adenylate cyclase-activating polypeptide (PACAP): discovery and current status of research. Regul Pept. 37:287-303.
4. Chartrel N, Tonon MC, Vaudry H, Conlon JM. 1991 Primary structure of frog pituitary adenylate cyclase-activating polypeptide (PACAP) and effects of ovine PACAP on frog pituitary. Endocrinology. 129:3367-3371.
5. Rawlings SR, Hezareh M. 1996 Pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP/vasoactive intestinal polypeptide receptors: action on the anterior pituitary gland. Endocr Rev. 17:4-29.
6. Christophe J. 1993 Type I receptors for PACAP (a neuropeptide even more important than VIP?). Biochim Biophys Acta. 1154:183-199.
7. Arimura A, Shioda S. 1995 Pituitary adenylate cyclase-activating polypeptide (PACAP) and its receptors: neuroendocrine and endocrine interaction. Front Neuroendocrinol. 16:53-88.
8. Ishihara T, Shigemoto R, Mori K, Takahashi K, Nagata S. 1992 Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide. Neuron. 8:811-819.
9. Lutz EM, Sheward WJ, West KM, Morrow JA, Fink G, Harmar AJ. 1993 The VIP-2 receptor: molecular characterization of a cDNA encoding a novel receptor for vasoactive intestinal polypeptide. FEBS Lett. 33:3-8.
10. Spengler D, Waeber C, Pantaloni C, et al. 1993 Differential signal transduction by five splice variants of the PACAP receptor. Nature. 365:170-175.
11. Ghatei MA, Takahashi K, Suzuki Y, Gardiner J, Jones PM, Bloom SR. 1993 Distribution, molecular characterization of pituitary adenylate cyclase-activating polypeptide and its precursor encoding messenger RNA in human and rat tissues. J Endocrinol. 36:159-166.
12. Yon L, Feuilloley M, Chartrel N, Arimura A, Fournier A, Vaudry H. 1993 Localization, characterization and activity of pituitary adenylate cyclase-activating polypeptide in the frog adrenal gland. J Endocrinol. 139:183-194.
13. Tabarin A, Chen D, Håkanson R, Sundler F. 1994 Pituitary adenylate cyclase-activating peptide in the adrenal gland of mammals: distribution, characterization and responses to drugs. Neuroendocrinology. 59:113-119.
14. Masuo Y, Tokito F, Matsumoto Y, Shimamoto N, Fujino M. 1994 Ontogeny of pituitary adenylate cyclase-activating polypeptide (PACAP) and its binding sites in the rat brain. Neurosci Lett. 170:43-46.
15. Tatsuno I, Somogyvari-Vigh A, Arimura A. 1994 Developmental changes of pituitary adenylate cyclase-activating polypeptide (PACAP) ands its receptors in the rat brain. Peptides. 15:55-60.
16. Basille M, Gonzalez BJ, Leroux P, Jeandel L, Fournier A, Vaudry H. 1993 Localization and characterization of PACAP receptors in the rat cerebellum during development: evidence for a stimulatory effect of PACAP on immature cerebellar granule cells. Neuroscience. 57:329-338.
17. Basille M, Gonzalez BJ, Fournier A, Vaudry H. 1994 Ontogeny of pituitary adenylate cyclase-activating polypeptide (PACAP) receptors in the rat cerebellum: a quantitative autoradiographic study. Dev Brain Res. 82:81-89.
18. Gonzalez BJ, Basille M, Vaudry D, Fournier A, Vaudry H. 1997 Pituitary adenylate cyclase-activating polypeptide (PACAP) promotes cell survival and neurite outgrowth in rat cerebellar neuroblasts. Neuroscience. 78:419-430.
19. Matsumoto H, Koyama C, Sawada T, et al. 1993 Pituitary folliculostellate-like cell line (TtT/GF) responds to novel hypophysiotropic peptide (pituitary adenylate cyclase-activating polypeptide), showing increased adenosine 3′, 5′-monophosphate and interleukin-6 secretion and cell proliferation. Endocrinology. 133:2150-2155.
20. Shivers B, Görcs T, Gottschall P. 1991 Two high-affinity binding sites for pituitary adenylate cyclase-activating polypeptide (PACAP) have different tissue distribution. Endocrinology. 128:3055-3065.
21. Watanabe T, Masuo Y, Matsumoto H, et al. 1992 Pituitary adenylate cyclase-activating polypeptide provokes cultured rat chromaffin cells to secrete adrenaline. Biochem Biophys Res Commun. 182:403-411.
22. Moller K, Sundler F. 1996 Expression of pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP type I receptors in the rat adrenal medulla. Regul Pept. 63:129-139.
23. Frödin M, Hannibal J, Wulff BS, Gammeltoft S, Fahrenkrug J. 1995 Neuronal localization of pituitary adenylate cyclase-activating polypeptide-38 in the adrenal medulla and growth inhibitory effect on chromaffin cells. Neuroscience. 65:599-608.
24. Tischler AS, Riseberg JC, Gray R. 1995 Mitogenic and antimitogenic effects of pituitary adenylate cyclase-activating polypeptide (PACAP) in adult rat chromaffin cell cultures. Neurosci Lett. 189:135-138.
25. Wolf N, Krieglstein K. 1995 Phenotypic development of neonatal rat chromaffin cells in response to adrenal growth factors and glucocorticoids: focus on pituitary adenylate cyclase-activating polypeptide. Neurosci Lett. 200:207-210.
26. Winter JSD. 1992 Fetal and neonatal adrenocortical development. In: James VHT, ed. The adrenal gland. 2nd ed. New York: Raven Press; 159-189.
27. Bocian-Sobkowska J, Malendowicz LK, Wozniak T. 1993 Cytological aspects of the human adrenal cortex development in the course of intra-uterine life. Histol Histopathol. 8:725-730.
28. Cooper MJ, Hutchins GM, Israel MA. 1990 Histogenesis of the human adrenal medulla. Am J Pathol. 137:605-615.
29. Ehrhart-Bornstein M, Breidert M, Guadanucci P, et al. 1997 17α-hydroxylase and chromogranin A in 6th week human fetal adrenals. Horm Metab Res. 29:30-32.
30. Chartrel N, Conlon JM, Danger JM, Fournier A, Tonon MC, Vaudry H. 1991 Characterization of melanotropin release-inhibiting factor (melanostatin) from frog brain: homology with human neuropeptide Y. Proc Natl Acad Sci USA. 6:249-255.
31. Laquerrière A, Leroux P, Gonzalez B, Bodenant C, Benoit R, Vaudry H. 1989 Distribution of somatostatin receptors in the brain of the frog Rana ridibunda: correlation with the localization of somatostatin-containing neurons. J Comp Neurol. 280:451-467.
32. Yon L, Chartrel N, Feuilloley M, et al. 1994 Pituitary adenylate cyclase-activating polypeptide stimulates both adrenocortical cells and chromaffin cells in the frog adrenal gland. Endocrinology. 135:2749-2758.
33. Streeter GL. 1920 Weight, sitting height, head size, foot length and menstrual age of the human embryo. Contr Embryol. 11:143-179.
34. Leroux P, Gonzalez BJ, Bucharles C, Vaudry H. 1991 Autoradiographic study of somatostatin receptors in the rat cerebellum. Methods Neurosci. 5:538-553.
35. Breault L, Lehoux JG, Gallo-Payet N. 1996 The angiotensin AT2 receptor is present in the fetal human adrenal gland throughout the second trimester of gestation. J Clin Endocrinol Metab. 81:3914-3922.
36. Gallo-Payet N, Payet MD. 1989 Excitation-secretion coupling: involvement of potassium channels in ACTH-stimulated rat adrenocortical cells. J Endocrinol. 120:409-421.
37. Salomon Y, Londos C, Rodbell M. 1974 A highly sensitive adenylate cyclase assay. Anal Biochem. 58:541-548.
38. Gallo-Payet N, Guillon G, Balestre MN, Jard S. 1986 Vasopressin induces breakdown of membrane phosphoinositides in adrenal glomerulosa and fasciculata cells. Endocrinology. 19:1042-1047.
39. Molenaar WM, Lee VMY, Trojanowski JQ. 1990 Early fetal acquisition of the chromaffin and neuronal immunophenotype by human adrenal medullary cells. An immunohistological study using monoclonal antibodies to chromogranin A, synaptophysin, tyrosine hydroxylase, and neuronal cytoskeletal proteins. Exp Neurol. 108:1-9.
40. Mazzochi G, Malendowicz LK, Meneghelli V, Gottardo G, Nussdorfer GG. 1993 Vasoactive intestinal polypeptide (VIP) stimulates hormonal secretion of the rat adrenal cortex in vitro: evidence that adrenal chromaffin cells are involved in the mediation of the mineralocorticoid, but not glucocorticoid secretagogue action of VIP. Biomed Res. 14:435-440.
41. Hinson JP, Ho MM, Vinson GP, Kapas S. 1996 Vasoactive intestinal peptide is a local regulator of adrenocortical function. Endocr Res. 22:831-838.
42. Bornstein SR, Haidan A, Ehrhart-Bornstein M. 1996 Cellular communication in the neuro-adrenocortical axis: role of vasoactive intestinal polypeptide (VIP). Endocr Res. 22:819-829.
43. 2+-dependent stimulatory effect of pituitary adenylate cyclase-activating polypeptide on catecholamine secretion from cultured porcine adrenal medullary chromaffin cells. Endocrinology. 132:1757-1765.
44. Pisegna JR, Wank SA. 1996 Cloning and characterization of the signal transduction of four splice variants of the human pituitary adenylate cyclase-activating polypeptide receptor. J Biol Chem. 271:17267-17274.
45. Marley PD, Cheung CY, Thomson KA, Murphy R. 1996 Activation of tyrosine hydroxylase by pituitary adenylate cyclase-activating polypeptide (PACAP-27) in bovine adrenal chromaffin cells. J Auton Nerv Syst. 60:141-146.
46. Neri G, Andreis P, Prayer-Galetti T, Rossi G, Malendowicz L, Nussdorfer GG. 1996 Pituitary adenylate cyclase-activating polypeptide enhances aldosterone secretion of human adrenal gland: evidence for an indirect mechanism, probably involving the local release of catecholamines. J Clin Endocrinol Metab. 81:169-173.
47. Gallo-Payet N, Pothier P, Isler H. 1987 On the presence of chromaffin cells in the adrenal cortex: their possible role in adrenocortical function. Biochem Cell Biol. 65:588-592.
48. Bornstein SR, Gonzalez-Hernandez JA, Ehrhart-Bornstein M, Adler G, Scherbaum WA. 1994 Intimate contact of chromaffin and cortical cells within the human adrenal gland forms the cellular basis for important intraadrenal interactions. J Clin Endocrinol Metab. 78:225-232.
49. Deutsch PJ, Shadlow VC, Barzilai N. 1993 38-amino acid form of pituitary adenylate cyclase-activating polypeptide induces process outgrowth in human neuroblastoma cells. J Neurosci Res. 35:312-320.
50. Vaudry D, Gonzalez BJ, Basille M, Anouar Y, Fournier A, Vaudry H. 1998 PACAP stimulates both c-fos gene expression and cell survival in rat cerebellar granule neurons through activation of the protein kinase A pathway. Neuroscience. 84:801-812.
51. Deutsch PJ, Sun Y. 1992 The 38-amino acid form of pituitary adenylate cyclase-activating polypeptide stimulates dual signaling cascades in PC12 cells and promotes neurite outgrowth. J Biol Chem. 267:5108-5113.